Multifocal Neuromodulation in Motor and Cognitive Function of People With Parkinson's Disease Trial N/A Unknown Feb. 16, 2021
A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease. Trial Phase 2 Completed Feb. 16, 2021
The SUSTAIN Study Compares the Effects of Sustained and Immediate-release Pramipexole on the noctUrnal Symptoms of paTients With Advanced ParkInsoN's Disease Who Also Take L-Dopa Trial Phase 4 Completed Feb. 15, 2021
Study of Factors Associated With the Volumetric and Areal Bone Mineral Density and Bone Strength in Parkinson's Disease Trial N/A Unknown Feb. 15, 2021
Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease Experiments 1 & 2 - Proj #3 Trial Phase 2 Completed Feb. 11, 2021
LRRK2 Activity and Markers of Parkinson's Disease in G2385R Carriers Trial N/A Completed Feb. 8, 2021
Evaluation of a Multimodal Neuroimaging Method for Diagnosis in Parkinsonian Syndromes Trial N/A Completed Feb. 8, 2021
Exploration of the Mechanism of Movement Improvement During RBD in Parkinson's Disease Using NIRS Trial N/A Completed Feb. 8, 2021
Neurophysiological Characteristics of Subthalamic Deep-brain Stimulation (STN-DBS) Trial N/A Withdrawn Feb. 2, 2021
Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175) Trial Phase 2 Completed Feb. 1, 2021
Utilization of Target Ranges to Treat Persons With Parkinson's Disease by Objective Measurement Using the PKG Trial N/A Withdrawn Jan. 31, 2021
Microbiota Modification for the Treatment of Motor Complication of Parkinson´s Disease Trial Phase 1 Completed Jan. 28, 2021
Crossover Target Engagement Study of Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease (Project #3 - Experiment 3 [UdallP3E3]) Trial Phase 2 Completed Jan. 26, 2021